Bayer AG - Company Overview and Analysis, 2023 Update
Summary
Bayer AG - Company Overview and Analysis, 2023 Update, reports key findings as of 18th August, 2023 based on market analysis and brand diversification by industry and geography.
Bayer AG (Bayer) is a German multinational pharmaceutical and biotechnology company that discovers, develops, manufactures, and commercializes a wide range of human health and agriculture products. The company manufactures and markets consumer health, pet care, cosmetics & toiletries (C&T), household, and baby care products. Most of the company’s sales come from the consumer health industry (96.4%). Bayer operates its business across all regions worldwide. Its major business is concentrated in North America, which accounted for 43.9% of value sales in 2022.
Scope
North America is the leading revenue generating region for Bayer
The consumer health industry is set to grow the fastest in North America
West Europe and Asia to present growth prospects for Bayer through 2027
Sentiment score sees a declining trend after November 2022
Reasons to Buy
Understand the challenges and opportunities for a specific company in order to tap into what is really impacting the industry.
Gain a broader appreciation of the fast-moving consumer goods industry by gaining insights from both within and outside of your sector.
Access valuable strategic take-outs to help direct future decision-making and inform new product development.